Search

everythinglearnresearchcommunity

for

Search:↓

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Don't combine abiraterone and spironolactone for prostate cancer treatment as it may worsen the disease.

Finasteride, selenium, and vitamin E may help prevent prostate cancer.

The study found a specific peptide that helps detect TGase 3 activity in skin and hair follicles.

Eupafolin nanoparticles help protect skin cells from damage caused by air pollution.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

Steroid sulfatase inhibitors could potentially treat hormone-related disorders like certain cancers, hair loss, acne, and improve cognitive dysfunction.

5α-reductase inhibitors may reduce male fertility and could be used for male contraception.

Enzalutamide, a prostate cancer drug, may help prevent COVID-19 by blocking the virus from entering lung cells.

JAK inhibitors, like ruxolitinib, may effectively treat frontal fibrosing alopecia.

New hybrid compound found to effectively prevent hair loss.

Proteolytic enzymes damaged hair follicle stem cells in transgenic mice.

Tetrathelmis tetrathele extract may help prevent hair loss and improve scalp health.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Elidel combined with tretinoin is more effective for treating alopecia areata than Elidel alone.

Some hair loss and prostate drugs might increase the risk of diabetes and heart disease.

The document's conclusion cannot be provided because the document is not available or cannot be read.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Combining cetirizine and topical steroids can effectively manage severe lichen planus pilaris.

EMT plays a key role in skin fibrosis and offers new therapy targets.

Ritlecitinib is safe and well-tolerated for treating alopecia areata in patients aged 12 and older.

Minoxidil boosts plasma renin activity, influenced by control plasma renin activity and changes in sympathetic tone.

Eclipta alba extract improved learning, memory, and stress-related ulcers in rats without affecting movement or causing anxiety.

Simvastatin/ezetimibe did not effectively treat severe alopecia areata and caused side effects in some patients.